Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis

BACKGROUND: Eosinophilic esophagitis (EoE) has been defined as “asthma of the esophagus” for the large number of similarities between the two diseases. Omalizumab is an anti-Immunoglobulin E (IgE) antibody currently approved only in allergic IgE-mediated severe persistent uncontrolled asthma and in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ital J Pediatr
Main Authors: Arasi, Stefania, Costa, Stefano, Magazzù, Giuseppe, Ieni, Antonio, Crisafulli, Giuseppe, Caminiti, Lucia, Chiera, Fernanda, Vaccaro, Mario, Del Giudice, Michele Miraglia, Pajno, Giovanni Battista
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4802852/
https://ncbi.nlm.nih.gov/pubmed/27000314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-016-0243-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares